KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Total Non-Current Liabilities (2016 - 2025)

Johnson & Johnson's Total Non-Current Liabilities history spans 17 years, with the latest figure at $104.7 billion for Q2 2025.

  • For Q2 2025, Total Non-Current Liabilities fell 3.37% year-over-year to $104.7 billion; the TTM value through Jun 2025 reached $104.7 billion, down 3.37%, while the annual FY2023 figure was $97.7 billion, 10.75% down from the prior year.
  • Total Non-Current Liabilities for Q2 2025 was $104.7 billion at Johnson & Johnson, down from $106.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $124.0 billion in Q2 2023 and bottomed at $93.7 billion in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $106.3 billion (2021), against an average of $106.0 billion.
  • The largest annual shift saw Total Non-Current Liabilities rose 20.16% in 2023 before it fell 18.66% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $108.3 billion in 2021, then fell by 7.7% to $100.0 billion in 2022, then decreased by 2.31% to $97.7 billion in 2023, then grew by 9.43% to $106.9 billion in 2024, then dropped by 2.11% to $104.7 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Total Non-Current Liabilities are $104.7 billion (Q2 2025), $106.9 billion (Q3 2024), and $108.3 billion (Q2 2024).